Subarachnoid Hemorrhage Surgical Devices Market Trends

Growth Drivers

• Emergence of minimally invasive surgical tools: The innovations in terms of neurosurgical and endovascular technologies have significantly boosted the adoption of minimally invasive techniques such as endovascular coiling. For instance, in May 2025, the U.S. FDA reported that it had accepted the nitinol-enhanced device by Embolization Inc., as a vascular embolization device, which is employed in managing aneurysms that cause subarachnoid hemorrhage.
• Increased access to neuro-specialty centers: Governments and private players are readily expanding the number of stroke centers and neuro-intervention facilities, which drives access to advanced treatment for SAH. In July 2024, Amrita Hospital reported that it has launched the Amrita Brain Centre for Children, which is a specialized center dedicated to pediatric neurological disorders, offering care in areas such as epilepsy, stroke, sleep and behavioral disorders, and metabolic diseases in children.
• Growing research, innovation & clinical evidence: There has been strong clinical evidence showcasing the effectiveness of the SAH surgical devices, creating an encouraging opportunity for both domestic & international players. In this regard, the November 2024 article published by NIH reported that a 15-year study demonstrated a considerable shift from microsurgical clipping to endovascular treatments, which has contributed to reduced mortality rates and improved patient outcomes, underscoring the growing adoption of endovascular devices in managing subarachnoid hemorrhage.

Epidemiology and Regional Variations of Hemorrhagic Stroke

Source: NIH, 2023

Challenges

• High treatment costs & reimbursement caps: This is the major factor limiting the uptake of subarachnoid hemorrhage surgical devices. Also, most of the advanced devices, such as embolic coils, flow diverters, and neurovascular stents, are highly expensive, leading to high out-of-pocket expenses for patients, especially in regions where there is limited healthcare coverage.
• Diagnostic access inequality: Subarachnoid hemorrhage often shows up with vague symptoms such as a really bad headache or nausea. Therefore, this necessitates the need for advanced neuroimaging techniques such as CT scans, MRIs, or angiography to make a proper diagnosis, making it challenging for emerging nations lacking appropriate diagnostic facilities.